Tengion, Inc. (TNGNQ)
Grows replacement organs from living cells to treat kidney disease and cancer patients.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+900.0%
The outlook
Tengion trades at its 52-week high of $0.0001, sitting above both its 50- and 200-day moving averages. Analyst coverage appears minimal or unavailable for this micro-cap stock. The StockGlow score leans bullish, though investors should note the extremely low price and thin liquidity typical of penny stocks.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$4,024
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—